U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H45NO5S
Molecular Weight 507.726
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 11
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEFAMULIN

SMILES

[H][C@@]12C(=O)CC[C@]13CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@@H]4CC[C@@H](N)C[C@H]4O

InChI

InChIKey=KPVIXBKIJXZQJX-CSOZIWFHSA-N
InChI=1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16?,17-,18+,20+,21+,22+,24-,25-,26+,27-,28-/m0/s1

HIDE SMILES / InChI

Molecular Formula C28H45NO5S
Molecular Weight 507.726
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 11 / 11
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 09:47:05 UTC 2023
Edited
by admin
on Sat Dec 16 09:47:05 UTC 2023
Record UNII
21904A5386
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEFAMULIN
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
LEFAMULIN [USAN]
Common Name English
ACETIC ACID, 2-(((1R,2R,4R)-4-AMINO-2-HYDROXYCYCLOHEXYL)THIO)-, (3AS,4R,5S,6S,8R,9R,9AR,10R)-6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER
Systematic Name English
(+)-LEFAMULIN
Common Name English
BC-3781
Code English
Lefamulin [WHO-DD]
Common Name English
lefamulin [INN]
Common Name English
LEFAMULIN [MI]
Common Name English
Code System Code Type Description
RXCUI
2198944
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
MERCK INDEX
m12169
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
ChEMBL
CHEMBL3291398
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
INN
9849
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
DAILYMED
21904A5386
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
LACTMED
Lefamulin
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
DRUG CENTRAL
5348
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
SMS_ID
100000176088
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
WIKIPEDIA
Lefamulin
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
FDA UNII
21904A5386
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
NCI_THESAURUS
C166531
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
DRUG BANK
DB12825
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
CAS
1061337-51-6
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
USAN
CD-31
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
PUBCHEM
58076382
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
EPA CompTox
DTXSID101027896
Created by admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
PRIMARY
Related Record Type Details
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TRANSPORTER -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
MAJOR
EXCRETED UNCHANGED
Following IV administration
AMOUNT EXCRETED
URINE
SALT/SOLVATE -> PARENT
BINDER->LIGAND
BINDING
EXCRETED UNCHANGED
Following IV administration
AMOUNT EXCRETED
FECAL
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC